1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7.
Assumptions and Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4. Voice of Customers
5. Global Precision
Oncology Market Outlook
5.1.
Market Size & Forecast
5.1.1. By Value
5.2.
Market Share & Forecast
5.2.1. By Product Type (Diagnostics, Therapeutics)
5.2.2. By Cancer Type (Breast Cancer, Cervical Cancer, Prostate Cancer,
Lung Cancer)
5.2.3. By End User (Hospitals & Diagnostic Laboratories,
Pharmaceutical & Biotechnology Companies, Healthcare Data Companies)
5.2.4. By Region
5.2.5. By Company (2023)
5.3.
Market Map
5.3.1. By Product Type
5.3.2. By Cancer Type
5.3.3. By End User
5.3.4. By Region
6. Asia Pacific
Precision Oncology Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Cancer Type
6.2.3. By End User
6.2.4. By Country
6.3.
Asia Pacific: Country Analysis
6.3.1. China Precision
Oncology Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Product Type
6.3.1.2.2.
By Cancer Type
6.3.1.2.3.
By End
User
6.3.2. India Precision
Oncology Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Product Type
6.3.2.2.2.
By Cancer Type
6.3.2.2.3.
By End
User
6.3.3. Australia Precision
Oncology Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Product Type
6.3.3.2.2.
By Cancer Type
6.3.3.2.3.
By End
User
6.3.4. Japan Precision
Oncology Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Product Type
6.3.4.2.2.
By Cancer Type
6.3.4.2.3.
By End
User
6.3.5. South Korea
Precision Oncology Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Product Type
6.3.5.2.2.
By Cancer Type
6.3.5.2.3.
By End
User
7. Europe Precision
Oncology Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Cancer Type
7.2.3. By End User
7.2.4.
By
Country
7.3.
Europe: Country Analysis
7.3.1. France Precision
Oncology Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product Type
7.3.1.2.2.
By Cancer Type
7.3.1.2.3.
By End
User
7.3.2. Germany Precision
Oncology Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product Type
7.3.2.2.2.
By Cancer Type
7.3.2.2.3.
By End
User
7.3.3. Spain Precision
Oncology Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Product Type
7.3.3.2.2.
By Cancer Type
7.3.3.2.3.
By End
User
7.3.4. Italy Precision
Oncology Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Product Type
7.3.4.2.2.
By Cancer Type
7.3.4.2.3.
By End
User
7.3.5. United Kingdom
Precision Oncology Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Product Type
7.3.5.2.2.
By Cancer Type
7.3.5.2.3.
By End
User
8. North America
Precision Oncology Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Cancer Type
8.2.3. By End User
8.2.4. By Country
8.3.
North America: Country Analysis
8.3.1. United States
Precision Oncology Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product Type
8.3.1.2.2.
By Cancer Type
8.3.1.2.3.
By End
User
8.3.2. Mexico Precision
Oncology Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product Type
8.3.2.2.2.
By Cancer Type
8.3.2.2.3.
By End
User
8.3.3. Canada Precision
Oncology Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product Type
8.3.3.2.2.
By Cancer Type
8.3.3.2.3.
By End
User
9. South America
Precision Oncology Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Cancer Type
9.2.3. By End User
9.2.4. By Country
9.3.
South America: Country Analysis
9.3.1. Brazil Precision
Oncology Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product Type
9.3.1.2.2.
By Cancer Type
9.3.1.2.3.
By End
User
9.3.2. Argentina Precision
Oncology Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product Type
9.3.2.2.2.
By Cancer Type
9.3.2.2.3.
By End
User
9.3.3. Colombia Precision
Oncology Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product Type
9.3.3.2.2.
By Cancer Type
9.3.3.2.3.
By End
User
10. Middle East and
Africa Precision Oncology Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Cancer Type
10.2.3. By End User
10.2.4. By Country
10.3.
MEA: Country Analysis
10.3.1. South Africa
Precision Oncology Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Product Type
10.3.1.2.2.
By Cancer Type
10.3.1.2.3.
By End
User
10.3.2. Saudi Arabia
Precision Oncology Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Product Type
10.3.2.2.2.
By Cancer Type
10.3.2.2.3.
By End
User
10.3.3. UAE Precision
Oncology Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Product Type
10.3.3.2.2.
By Cancer Type
10.3.3.2.3.
By End
User
10.3.4. Egypt Precision
Oncology Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1.
By Product Type
10.3.4.2.2.
By Cancer Type
10.3.4.2.3.
By End
User
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends &
Developments
12.1.
Recent Developments
12.2.
Product Launches (If Any)
12.3.
Mergers & Acquisitions (If Any)
13. Global Precision
Oncology Market: SWOT Analysis
14. Porter’s Five Forces
Analysis
14.1.
Competition in the Industry
14.2.
Potential of New Entrants
14.3.
Power of Suppliers
14.4.
Power of Customers
14.5.
Threat of Substitute Product
15. Competitive
Landscape
15.1. Thermo Fisher Scientific Inc.
15.1.1.
Business Overview
15.1.2.
Company Snapshot
15.1.3.
Products & Services
15.1.4.
Financials (In case of listed)
15.1.5.
Recent Developments
15.1.6.
Key Personnel Details
15.1.7.
SWOT Analysis
15.2. Invitae Corporation
15.3. Qiagen N.V.
15.4. Illumina, Inc.
15.5. Laboratory
Corporation Of America Holding
15.6. Exact Sciences Corporation
15.7. Rain Oncology Inc.
15.8. Strata Oncology,
Inc.
15.9. Xilis, Inc.
15.10. Variantyx, Inc.
16. Strategic
Recommendations
17. About Us & Disclaimer